1 / 49

GYN GEC-ESTRO /ICRU Target Concept

GYN GEC-ESTRO /ICRU Target Concept. Richard Pötter Medical University Vienna. GYN GEC ESTRO RECOMMENDATIONS-BACKGROUND From 2D to 3D/4D. Historical difficulties in communicating results of cervical BT due to different traditions (60 Gy reference volume, point A…, midline block)

maryalvarez
Télécharger la présentation

GYN GEC-ESTRO /ICRU Target Concept

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GYN GEC-ESTRO/ICRUTarget Concept Richard Pötter Medical University Vienna

  2. GYN GEC ESTRO RECOMMENDATIONS-BACKGROUND From 2D to 3D/4D Historical difficulties in communicating results of cervical BT due to different traditions (60 Gy reference volume, point A…, midline block) • CTV according to GTV at diagnosis? • CTV according to GTV at BT? Building the tower of Babel (confusion of languages) Brueghel, 16th century (1563) Vienna, Museum of Fine Arts We need a common language!

  3. Target volume concepts High Risk CTV : GTV at time of brachytherapy In all cases includes: • GTV + wholecervix • Presumedtumour extension in adjacent tissues • Clinicalassessment • Residualgrey zones on MRI NO SAFETY MARGINS IntermediateRisk CTV : GTV at time of diagnosis In all cases includes: • HR-CTV • integrates initial GTV SAFETY MARGINS : 1-1.5 cm cranially 0.5cm antero-posteriorly 1cm laterally

  4. Target volume concepts High Risk CTV (IB1): • GTV at time of brachytherapy • In all cases includes: • Wholecervix • MRI and clinicalassessment • NO SAFETY MARGINS

  5. Stage IB1 IR CTV GTV HR CTV

  6. Stage IB1 HR CTV GTV IR CTV

  7. Stage IB1 7

  8. Stage IB1 8

  9. Stage IB1 9

  10. Adaptive MRI based planning concept Dimopoulos et al. IJROBP 2006

  11. w w h h t t Findings at time of diagnosis Findings at time of brachytherapy Dimensions (cm): Width: 3.5 Thickness: 2 Height: 2 Vaginal inv.: 0 Dimensions (cm): Width: 7 Thickness:>5 Height: >5 Vaginal inv.: 0.5 (right fornix) Fig.5.1

  12. Various patterns of tumor response and adaptive CTV Residual GTV Residual pathologic tissue Adaptive CTV ICRU/GEC ESTRO report 88 Fig. 5.4

  13. Overview of adaptive target concept in cervix cancer ICRU/GEC ESTRO report 88 Fig. 5.9-11

  14. Initial GTV, Residual GTV, Residual Pathologic Tissue expansive with spiculae + infilt. part → grey zones in the PM PL PL expansive with spiculae → no patholgic tissue in the PM WR WR infiltrative outer half → grey and bright zones HU HU

  15. Target volume concepts High Risk CTV (IB2): • Residual GTV at time of brachytherapy (bright (MRI)) • In all cases includes: • Wholecervix • (intra-uterine GTV extension) • NO SAFETY MARGINS

  16. w h t Stage IB2 : initial clinical examination Infiltrating Exophytic Cervix Vagina Parametrium Rectum or Bladder Dimensions (cm): Width : 6 Thickness : 5 Height : 5

  17. Stage IB2 : initial MRI 6 cm 5 cm 6 cm

  18. w h t Stage IB2 : at the time of brachytherapy Infiltrating Exophytic Cervix Vagina Parametrium Rectum or Bladder Dimensions (cm): Width : 2.5 Thickness : 2 Height : 2.5

  19. Stage IB2 : at the time of brachytherapy

  20. Stage IB2

  21. Stage IB2

  22. Stage IB2

  23. Stage IB2

  24. Target volume concepts High Risk CTV (IIB): • Residual GTV at time of brachytherapy • Residualpathologic tissue • at time of brachytherapy • In all cases includes: • Wholecervix • residual GTV (clinical and MRI) • residualpathologic tissue • (clinical and MRI (grey zones)) • locatedwithin the initial GTV • NO SAFETY MARGINS

  25. Overview of adaptive target concept in cervix cancer ICRU/GEC ESTRO report 88 Fig. 5.9-11

  26. w h t Stage IIB : initial clinical examination Infiltrating Exophytic Cervix Vagina Parametrium Rectum or Bladder Dimensions (cm): Width : 5 Thickness:5 Height : 5 Fornix involv 1

  27. Stage IIB : initial MRI 50 mm 50 mm 52 mm

  28. w h t Stage IIB : at the time of brachytherapy Infiltrating Exophytic Cervix Vagina Parametrium Rectum or Bladder Dimensions (cm): Largeur : 3 Epaisseur : 3 Hauteur : 3 Env. vaginal : 1

  29. Stage IIB : MRI at the time of brachytherapy 30 mm 30 mm 30 mm

  30. Stage IIB GTV Tumor at time of diagnosis IR CTV GTV HR CTV

  31. Stage IIB GTV Tumor at time of diagnosis. HR CTV GTV IR CTV

  32. Stage IIB 50 mm 50 mm 52 mm 30 mm 30 mm 30 mm 32

  33. Stage IIB 50 mm 50 mm 52 mm 30 mm 30 mm 30 mm 33

  34. Stage IIB 50 mm 50 mm 52 mm 30 mm 30 mm 30 mm 34

  35. Target volume concepts High Risk CTV (IIIB): • Residual GTV and • Residualpathologic tissue • at time of brachytherapy • In all cases includes: • Wholecervix • residual GTV (clinical and MRI) • residualpathologic tissue • (clinical and MRI (grey zones)) • locatedwithin the initial GTV • NO SAFETY MARGINS

  36. Overview of adaptive target concept in cervix cancer ICRU/GEC ESTRO report 88 Fig. 5.9-11

  37. w h t Stage IIIB : initial clinical examination Infiltrating Exophytic Cervix Vagina Parametrium Rectum or Bladder Dimensions (cm): Width : 6 Thickness :4 Height : 4

  38. Stage IIIB : initial MRI 40 mm 45 mm 62 mm

  39. w h t Stage IIIB : at the time of brachytherapy Infiltrating Exophytic Cervix Vagina Parametrium Rectum or Bladder Dimensions (cm): Width: 4.5 Thickness : 3 Height : 3

  40. Stage IIIB : MRI at the time of brachytherapy 30 mm 30 mm 45 mm 40

  41. Stage IIIB 30 mm 30 mm 30 mm 41

  42. Stage IIIB 30 mm 30 mm 30 mm 42

  43. Stage IIIB 30 mm 30 mm 30 mm 43

  44. Stage IIIB 44

  45. Stage IIIB 45

  46. Stage IIIB 46

  47. Stage IIIB 47

  48. cervix HR and IR-CTVExtent at diagnosis and degree of remission Initial tumour extension Residual disease HR-CTV cervix IR-CTV Complete remission No remission Good partial remission Poor partial remission 10 mm 10 mm > 10 mm 10 mm cervix cervix cervix > 10 mm 10 mm 10 mm

  49. cervix endometrium vagina B HR-CTV IR-CTV B IR-CTV HR-CTV GTV S VC R HR-CTV IR-CTV B GTV GTV R S R B Gyn GEC ESTRO Recommendationsare applicable for Gyn BT in general (vagina, endometrium, vulva, recurrent tumours) Petric, Pötter, van Limbergen, Haie-Meder: Adaptive Contouring of CTV and Organs at Risk in: Viswanathan, Erickson, Kirisits, Pötter (eds): Gynaecologic RadiationTherapy: Novel approaches to Image-Guidance and Management, 2010

More Related